BiotechTube
Home/Genervon Biopharmaceuticals/Dorothy Ko
DK

Dorothy Ko

Leadership Team

Genervon Biopharmaceuticals

Therapeutic Areas

Neurodegenerative Diseases

Genervon Biopharmaceuticals Pipeline

DrugIndicationPhase
GM6Amyotrophic Lateral Sclerosis (ALS)Phase 2

Leadership Team at Genervon Biopharmaceuticals

WK
Winston Ko
Chief Executive Officer, Chairman of the Board
View full Genervon Biopharmaceuticals profile